Skip to content
Resero Analytics

Our AI Approach

More AI doesn't make a better product. The right AI, in the right place, does.

AI models will change every six months. Your data foundation shouldn't have to.

Why the data matters most

Same question. Two very different answers.

Ask an AI model one simple question about your study history. What comes back depends on the data underneath it.

The question

“Show every prior study with a loss of red cell mass.”

Against free-text history

  • Misses studies that say “anemia” instead
  • Invents a study that doesn’t exist
  • Cites nothing you can check

Against controlled, traceable data

  • Reads “anemia”, “RBC decreased” and “erythrocytes, decreased” as one term
  • Returns every matching study
  • Links each result to its source record

Same model. The difference was the data.

Levels of AI use

Ask instead: how much does the AI decide?

Labels like machine learning, generative AI and agentic AI describe how something is built, not who makes the decision. We describe every AI feature by how much it decides.

  1. L0

    None

    AI
    Nothing
    Human
    Does it all
  2. L1Most value

    Assist

    AI
    Finds, searches and summarizes on request
    Human
    Does the work
  3. L2Most value

    Draft

    AI
    Writes a first draft
    Human
    Reviews every item
  4. L3Most value

    Recommend

    AI
    Analyzes and flags, with cited evidence
    Human
    Decides
  5. L4

    Delegated

    AI
    Runs a defined task end to end
    Human
    Approves at checkpoints
  6. L5

    Autonomous

    AI
    Acts with no human in the loop
    Human
    Not for GLP decisions

Most value today sits at L1–L3.

Finding, drafting and flagging with cited evidence save real time, and the scientist still decides.

Choose the level per task, not per organization.

A report draft and a raw study measurement carry different risks. Each task gets its own level.

L0 is a choice, not a gap.

Where the answer must be exact, no AI is the right answer. And L5 is not for GLP decisions.

Promise 1 of 3

Grounded

The AI only uses what it is allowed to know: approved facts, fixed settings and reviewed prompts.

Settings

Fixed per task, recorded with every output

  • Which model and version
  • Temperature
  • Which tools it may use

Prompts

Treated like SOPs

  • Written by experts
  • Reviewed and versioned
  • Under change control

Data

The facts the AI may use

  • One controlled term per finding
  • Full context: species, dose, day, instrument
  • Provenance for every answer

Reference sources

Ranked, when the AI uses them

  • GLP studies and FDA reviews first
  • Then peer-reviewed literature, rated for reliability (Klimisch)
  • Each source’s tier shown on every output

Promise 2 of 3

Scientists stay in control

AI earns trust when scientists can see it and change it.

“AI should amplify the study director’s judgment, not replace it. No black boxes.”

Visibility

For any AI output, see the data it used, the prompt and settings, and citations back to source records.

Changeability

Adjust prompts and parameters within guardrails. Every change lands in the audit trail.

Curated skills

Packaged AI workflows for common tasks. Experts write them once; each is versioned and validated like any method.

Promise 3 of 3

Risks handled up front

Every AI step is something to validate, monitor and explain to QA and regulators. So we name the risks and design for them.

Hallucination
Grounding plus mandatory citations
Over-reliance
A level chosen per task; humans decide
Unvalidated change
Settings and prompts under change control

Where each level belongs

  • L0where the answer must be exact
  • L2–L3where a draft or a flag saves time
  • L4only where the data can carry it

Our products

Where our products sit today

The level is set per task, not per product. L0 is a choice, not a gap.

L0 · None
L1 · Assist

Not used today.

L2 · Draft
L3 · Recommend
L4 · Delegated

Not used today.

L5 · Autonomous

Not used. Not for GLP decisions.

L0 tasks such as study data and PK analysis use no AI by design: the answer must be exact. No product uses L5.

What's next · Vision, not product

Where this can go

These are ideas we are working toward with the industry. They are not features you can buy today.

Virtual control groups

  • Control matching: pick historical controls that match on strain, sex, age, vendor, diet, facility and instrument, and show why each qualified
  • Drift monitoring: flag shifts from an analyzer change, a new colony or a season before the data is used
  • Fewer concurrent controls: an auditable, statistically justified case per study that serves the 3Rs

New approach methodologies

  • Connect NAMs to animal history: line up in vitro and organ-chip readouts against structured in vivo results
  • Weight of evidence: gather NAM, in silico and limited in vivo evidence into one traceable package for the study director

Open study-data APIs

“A FHIR for nonclinical data”

Today SEND is a file, produced at the end of the study. Standard APIs would keep the data live while the study runs, in CDISC controlled terminology.

  • Study
  • Subject
  • Dose
  • Observation
  • Specimen
  • Finding
  • Live visibility for sponsors
  • Any AI can connect
  • Easy sharing between sponsors and CROs
  • No lock-in

An invitation to the industry, not a product.

Every one depends on the foundation: instrument-level traceability and controlled terminology. That is what TurboPlatform builds, from protocol to report.

One question to ask

“Ask any vendor, us included: why is AI in this step, at this level, and who decides?”
From “AI, Now and Next,” our talk at ACT 2026.

Talk to us about AI in your study workflow

We will show you where AI helps, at what level, and where we chose not to use it.